We describe a 39-year-old woman with an apparent captopril-induced, contact
mucosal-dominant pemphigus vulgaris and angioedema, who took captopril during a bout
of arterial hypertension. This exposure suggests that captopril and pathophysiology
of angioedema stimulated the development of pemphigus vulgaris, which was diagnosed
using the novel, indirect immunofluorescence BIOCHIP mosaic, with the modification to
detect serum IgG4 autoantibodies. We discuss the patient, who experienced a chain of
events leading to the active stage of pemphigus vulgaris, and review concepts of
pemphigus vulgaris inducible by drugs and pathological immunity.